Endocrine Reviews

Papers
(The H4-Index of Endocrine Reviews is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway648
Papillary Craniopharyngioma: An Integrative and Comprehensive Review311
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”237
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future236
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies215
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases196
DNA Damage and Repair in Thyroid Physiology and Disease181
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes133
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention133
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story131
The Molecular Biology of Midgut Neuroendocrine Neoplasms121
Effects of Maternal Vitamin D Supplementation on Childhood Health119
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity116
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”111
Calcium-sensing receptor regulation of gastrointestinal hormone secretion94
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies93
The Biology and Clinical Implications of PCSK790
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism89
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?84
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors75
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status74
Estrogen Receptor Signaling in the Immune System72
Contemporary Biological Insights and Clinical Management of Craniopharyngioma70
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas69
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”68
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review64
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia63
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction62
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance60
The Metabolic Role and Therapeutic Potential of the Microbiome60
Adiponectin and Adiponectin Receptors in Atherosclerosis57
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases55
The Cortisol Awakening Response: Regulation and Functional Significance55
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood54
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling52
Imaging of Pheochromocytomas and Paragangliomas49
Molecular and Clinical Spectrum of Primary Hyperparathyroidism48
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease48
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease48
Brown Adipose Tissue—A Translational Perspective47
G Protein-coupled and Membrane Tyrosine Kinase Receptor Relationships Yield Therapeutic Opportunities45
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications45
Erratum to: Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment44
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy43
Protective Factors and the Pathogenesis of Complications in Diabetes43
0.040494918823242